Literature DB >> 2996961

Insulin-gene flanking sequences, diabetes mellitus and atherosclerosis: a review.

T Mandrup-Poulsen, D Owerbach, J Nerup, K Johansen, J Ingerslev, A T Hansen.   

Abstract

A highly polymorphic locus flanking the human insulin gene contains two major size classes of DNA restriction fragments, which segregate in families as stable genetic elements. The L-allele, i.e. fragments with an average size of about 600 base-pairs seems to be a weak genetic marker for Type 1 (insulin-dependent) diabetes mellitus, whereas the U-allele, i.e. fragments of an average size of about 2500 base-pairs hitherto has been associated with Type 2 (non-insulin-dependent) diabetes mellitus and diabetic hypertriglyceridaemia. The most recent reports on this subject do not confirm an association between the U-allele and Type 2 diabetes. Our own studies indicate that the U-allele is a fairly strong marker for the development of atherosclerosis (relative risk for U-carriers 3.36). The putative functions of the polymorphic region in atherogenesis and the relation of this region to other genetic markers for atherosclerosis are not known.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2996961     DOI: 10.1007/bf00281989

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  42 in total

1.  Islet beta-cell function and polymorphism in the 5'-flanking region of the human insulin gene.

Authors:  M A Permutt; P Rotwein; T Andreone; W K Ward; D Porte
Journal:  Diabetes       Date:  1985-04       Impact factor: 9.461

2.  Polymorphism in the 5'-flanking region of the human insulin gene and its possible relation to type 2 diabetes.

Authors:  P Rotwein; R Chyn; J Chirgwin; B Cordell; H M Goodman; M A Permut
Journal:  Science       Date:  1981-09-04       Impact factor: 47.728

3.  Maturity onset diabetes of the young is not linked to the insulin gene.

Authors:  J I Bell; J S Wainscoat; J M Old; C Chlouverakis; H Keen; R C Turner; D J Weatherall
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-19

4.  Sequence of the human insulin gene.

Authors:  G I Bell; R L Pictet; W J Rutter; B Cordell; E Tischer; H M Goodman
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

5.  Insulin gene analysis in a family with maturity-onset diabetes of the young.

Authors:  T Andreone; S Fajans; P Rotwein; M Skolnick; M A Permutt
Journal:  Diabetes       Date:  1985-02       Impact factor: 9.461

6.  Possible association between DNA sequences flanking the insulin gene and atherosclerosis.

Authors:  D Owerbach; K Johansen; P Billesbølle; S Poulsen; M Schroll; J Nerup
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

7.  Insulin and apolipoprotein A-1/C-III gene polymorphisms relating to hypertriglyceridaemia and diabetes mellitus.

Authors:  N I Jowett; A Rees; L G Williams; J Stocks; M A Vella; G A Hitman; J Katz; D J Galton
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

8.  Analysis of the regions flanking the human insulin gene and sequence of an Alu family member.

Authors:  G I Bell; R Pictet; W J Rutter
Journal:  Nucleic Acids Res       Date:  1980-09-25       Impact factor: 16.971

9.  DNA sequences flanking the insulin gene on chromosome 11 confer risk of atherosclerosis.

Authors:  T Mandrup-Poulsen; D Owerbach; S A Mortensen; K Johansen; H Meinertz; H Sørensen; J Nerup
Journal:  Lancet       Date:  1984-02-04       Impact factor: 79.321

10.  Diabetic hypertriglyceridaemia and related 5' flanking polymorphism of the human insulin gene.

Authors:  N I Jowett; L G Williams; G A Hitman; D J Galton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-14
View more
  1 in total

1.  Possible correlation between non-insulin dependent diabetes mellitus (NIDDM) and restriction fragment length polymorphism (RFLP) of the 5'-flanking region of insulin gene in Korean diabetic population.

Authors:  S W Kim; I M Yang; J W Kim; Y S Kim; Y K Choi
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.